Logo image of ZUO

Zuora Inc (ZUO) Stock Fundamental Analysis

NYSE:ZUO - New York Stock Exchange, Inc. - US98983V1061 - Common Stock - Currency: USD

10.02  +0.03 (+0.3%)

After market: 10.11 +0.09 (+0.9%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ZUO. ZUO was compared to 282 industry peers in the Software industry. ZUO may be in some trouble as it scores bad on both profitability and health. ZUO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ZUO had positive earnings in the past year.
ZUO had a positive operating cash flow in the past year.
ZUO had negative earnings in each of the past 5 years.
In multiple years ZUO reported negative operating cash flow during the last 5 years.
ZUO Yearly Net Income VS EBIT VS OCF VS FCFZUO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

ZUO has a Return On Assets (-8.63%) which is comparable to the rest of the industry.
ZUO has a Return On Equity of -40.16%. This is in the lower half of the industry: ZUO underperforms 65.94% of its industry peers.
Industry RankSector Rank
ROA -8.63%
ROE -40.16%
ROIC N/A
ROA(3y)-20.14%
ROA(5y)-19.7%
ROE(3y)-104.33%
ROE(5y)-81.24%
ROIC(3y)N/A
ROIC(5y)N/A
ZUO Yearly ROA, ROE, ROICZUO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

ZUO has a Gross Margin (67.42%) which is in line with its industry peers.
ZUO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ZUO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.86%
GM growth 5Y5.53%
ZUO Yearly Profit, Operating, Gross MarginsZUO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

ZUO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ZUO has more shares outstanding
Compared to 5 years ago, ZUO has more shares outstanding
The debt/assets ratio for ZUO is higher compared to a year ago.
ZUO Yearly Shares OutstandingZUO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
ZUO Yearly Total Debt VS Total AssetsZUO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ZUO has an Altman-Z score of 0.88. This is a bad value and indicates that ZUO is not financially healthy and even has some risk of bankruptcy.
ZUO has a worse Altman-Z score (0.88) than 66.30% of its industry peers.
ZUO has a debt to FCF ratio of 5.17. This is a neutral value as ZUO would need 5.17 years to pay back of all of its debts.
ZUO has a Debt to FCF ratio (5.17) which is in line with its industry peers.
A Debt/Equity ratio of 2.00 is on the high side and indicates that ZUO has dependencies on debt financing.
ZUO has a worse Debt to Equity ratio (2.00) than 83.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 5.17
Altman-Z 0.88
ROIC/WACCN/A
WACC13.48%
ZUO Yearly LT Debt VS Equity VS FCFZUO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ZUO has a Current Ratio of 2.62. This indicates that ZUO is financially healthy and has no problem in meeting its short term obligations.
ZUO has a Current ratio of 2.62. This is in the better half of the industry: ZUO outperforms 71.38% of its industry peers.
ZUO has a Quick Ratio of 2.62. This indicates that ZUO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ZUO (2.62) is better than 71.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.62
Quick Ratio 2.62
ZUO Yearly Current Assets VS Current LiabilitesZUO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 241.18% over the past year.
ZUO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.80%.
ZUO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.93% yearly.
EPS 1Y (TTM)241.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)6.8%
Revenue growth 3Y12.23%
Revenue growth 5Y12.93%
Sales Q2Q%6.45%

3.2 Future

Based on estimates for the next years, ZUO will show a very strong growth in Earnings Per Share. The EPS will grow by 30.13% on average per year.
ZUO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.73% yearly.
EPS Next Y72.16%
EPS Next 2Y32.08%
EPS Next 3Y30.13%
EPS Next 5YN/A
Revenue Next Year6.33%
Revenue Next 2Y6.68%
Revenue Next 3Y9.07%
Revenue Next 5Y18.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZUO Yearly Revenue VS EstimatesZUO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
ZUO Yearly EPS VS EstimatesZUO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 17.28, which indicates a rather expensive current valuation of ZUO.
ZUO's Price/Earnings ratio is rather cheap when compared to the industry. ZUO is cheaper than 84.06% of the companies in the same industry.
When comparing the Price/Earnings ratio of ZUO to the average of the S&P500 Index (27.45), we can say ZUO is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 17.40, the valuation of ZUO can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZUO indicates a rather cheap valuation: ZUO is cheaper than 83.70% of the companies listed in the same industry.
ZUO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.28
Fwd PE 17.4
ZUO Price Earnings VS Forward Price EarningsZUO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ZUO is valued cheaply inside the industry as 82.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.71
EV/EBITDA N/A
ZUO Per share dataZUO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ZUO's earnings are expected to grow with 30.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y32.08%
EPS Next 3Y30.13%

0

5. Dividend

5.1 Amount

ZUO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Zuora Inc

NYSE:ZUO (2/13/2025, 8:11:32 PM)

After market: 10.11 +0.09 (+0.9%)

10.02

+0.03 (+0.3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-09 2024-12-09/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners87.14%
Inst Owner Change-96.7%
Ins Owners1.09%
Ins Owner Change-30.82%
Market Cap1.55B
Analysts49.09
Price Target10.2 (1.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.42%
Min EPS beat(2)40.81%
Max EPS beat(2)98.02%
EPS beat(4)4
Avg EPS beat(4)83.96%
Min EPS beat(4)40.81%
Max EPS beat(4)137.62%
EPS beat(8)8
Avg EPS beat(8)363.75%
EPS beat(12)11
Avg EPS beat(12)244.75%
EPS beat(16)14
Avg EPS beat(16)191.94%
Revenue beat(2)1
Avg Revenue beat(2)0.62%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.46%
Revenue beat(4)1
Avg Revenue beat(4)0.03%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)1.46%
Revenue beat(8)3
Avg Revenue beat(8)0.03%
Revenue beat(12)5
Avg Revenue beat(12)0%
Revenue beat(16)9
Avg Revenue beat(16)0.54%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 17.28
Fwd PE 17.4
P/S 3.42
P/FCF 21.71
P/OCF 18.51
P/B 8.4
P/tB 17.76
EV/EBITDA N/A
EPS(TTM)0.58
EY5.79%
EPS(NY)0.58
Fwd EY5.75%
FCF(TTM)0.46
FCFY4.61%
OCF(TTM)0.54
OCFY5.4%
SpS2.93
BVpS1.19
TBVpS0.56
PEG (NY)0.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.63%
ROE -40.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.42%
FCFM 15.75%
ROA(3y)-20.14%
ROA(5y)-19.7%
ROE(3y)-104.33%
ROE(5y)-81.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.86%
GM growth 5Y5.53%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 5.17
Debt/EBITDA N/A
Cap/Depr 64.05%
Cap/Sales 2.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.62
Quick Ratio 2.62
Altman-Z 0.88
F-Score5
WACC13.48%
ROIC/WACCN/A
Cap/Depr(3y)57.33%
Cap/Depr(5y)87.66%
Cap/Sales(3y)2.64%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y72.16%
EPS Next 2Y32.08%
EPS Next 3Y30.13%
EPS Next 5YN/A
Revenue 1Y (TTM)6.8%
Revenue growth 3Y12.23%
Revenue growth 5Y12.93%
Sales Q2Q%6.45%
Revenue Next Year6.33%
Revenue Next 2Y6.68%
Revenue Next 3Y9.07%
Revenue Next 5Y18.73%
EBIT growth 1Y31.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year138.12%
EBIT Next 3Y49.23%
EBIT Next 5YN/A
FCF growth 1Y2125.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y987.37%
OCF growth 3YN/A
OCF growth 5YN/A